Please Wait
Applying Filters...

Annual Sales of TD-4208; GSK-1160724;[1-[2-[[4-[(4-carbamoylpiperidin-1-yl)methyl]benzoyl]-methylamino]ethyl]piperidin-4-yl] N-(2-phenylphenyl)carbamate reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 442,770Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Yupelri

PharmaCompass

01

Brand Name : Yupelri

Revefenacin

arrow
34th IFSCC
Not Confirmed

Brand Name : Yupelri

arrow
34th IFSCC
Not Confirmed

Revefenacin

Main Therapeutic Indication : Respiratory Diseases

Currency : USD

2022 Revenue in Millions : 202

2021 Revenue in Millions : 162

Growth (%) : 25

blank

02

Brand Name : Yupelri

Revefenacin

arrow
34th IFSCC
Not Confirmed

Brand Name : Yupelri

arrow
34th IFSCC
Not Confirmed

Revefenacin

Main Therapeutic Indication : Respiratory Diseases

Currency : USD

2023 Revenue in Millions : 221

2022 Revenue in Millions : 202

Growth (%) : 9

blank